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Abstract
Objective: To evaluate the psychosocial impact of taking part in repeated testing for human
papillomavirus (HPV) in the context of cervical cancer screening.
Methods: In-depth interviews were carried out with 30 women who were HPV positive with
normal cytology at trial baseline, and attended for a repeat HPV test 12 months later.
Interview transcripts were analysed qualitatively using Framework Analysis to identify
emergent themes.
Results: Although women often experienced serious negative emotional consequences at the
time of their ﬁrst positive result, these did not generally last during the year between tests once
questions about HPV had been resolved. The emotional impact of testing positive a second time
was greater for many women, sometimes causing them to overcome their embarrassment about
having a sexually transmitted infection in order to disclose their result and seek support. Among
the women interviewed there was an overwhelming preference for immediate colposcopy rather
than continued surveillance for persistent HPV. This was associated with the desire for a speedy
resolution, and fears about progression to cancer.
Conclusions: Although most women did not appear to suﬀer on-going anxiety while waiting
for a second HPV test, this seemed contingent on their information needs being met. Women
appeared to be more distressed by a second HPV positive result than a single one, and
expressed a clear preference for immediate colposcopy over continued surveillance. This ﬁnding
might have implications for the way in which HPV testing could be used in cervical cancer
screening programmes.
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Introduction
There is growing interest in the possible uses of
testing for high-risk types of human papillomavirus
(HPV) in cervical cancer screening and the manage-
ment of cervical intraepithelial neoplasia (CIN).
HPV testing is now approved in the US [1,2] and its
role is being evaluated in several studies in the UK.
Alongside clinical and economic considerations, it
has been argued that psychosocial issues also need
to be taken into account when deciding whether
and how to introduce HPV testing [3,4]. A few
studies have indicated that testing positive for HPV
may impose a signiﬁcant psychological burden on
the women taking part in screening, over and
above the impact of an abnormal smear result [5–
7]. This seems to be due, at least in part, to the fact
that as a sexually transmitted infection (STI), HPV
carries connotations of stigma and raises issues for
relationships that are not commonly experienced
when receiving an abnormal smear result. Anxiety
is further exacerbated by a lack of understanding of
HPV. But so far no studies have evaluated the
impact of participation in repeated HPV tests. If
HPV testing is used as a surveillance tool for
women with mildly abnormal cytology, or as a
primary screening test, many women may undergo
repeated tests, and the impact of this must be
evaluated. This study takes a ﬁrst step towards this
evaluation using qualitative methods to explore
women’s experiences and concerns.
The study addresses three aspects of responses to
repeated testing for HPV. Firstly we investigated
whether women experience long-term anxiety and
distress about being HPV positive while waiting for
their second test. On-going anxiety has been found
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in some women with mildly abnormal cytology
who are managed by surveillance [8–10] and it is
possible that this could be more severe among
women who are HPV positive, as the psychosocial
burden of testing positive for HPV seems to be
greater than the impact of an abnormal smear
result [5–7]. There is currently no eﬀective means of
treating HPV, so women may face on-going
positive status without resolution.
Secondly, we examined women’s responses to
their second HPV result. Two aspects of their
responses were explored: (i) emotional responses to
testing either positive or negative for the virus; (ii)
the impact of the second result on disclosure
behaviour. For each of these aspects, changes
between the ﬁrst and second HPV test result were
explored.
Finally we were interested in women’s choice of
management of persistent HPV infection. In
general, women have been found to express a
preference for colposcopy over cytological surveil-
lance for the management of mildly abnormal
smear results [9,11]. However this was not the case
in a recent trial in which women given the option of
immediate colposcopy or cytological surveillance
were fairly evenly divided in their management
choices [12]. We explored the reasons for women’s
preferences for either immediate colposcopy or
repeated HPV testing after 12 months.
As the study addressed questions that are
sensitive in nature and about which little is
currently known, in-depth interviews and qualita-
tive analysis methods were used to ensure that the
ﬁndings were grounded in the accounts of the
participants [13].
Methods
Sample
With the approval of the North West Multi-centre
Research Ethics Committee, 30 women were
recruited from the ARTISTIC trial of HPV testing
in Manchester, UK (see http://www.ncchta.org/
projectdata/1 project record notpublished.asp?
PjtId¼ 1162). This sample size was adequate to
ensure inclusion of women with a range of
experiences and from a range of backgrounds,
while still being small enough to allow in-depth
analysis of the data. All women in this study were
selected having tested HPV positive with normal
cytology at the trial baseline. The recommended
follow-up in the trial for such women was a repeat
HPV test at 12 months. Women were recruited to
the interview study following participation in the
second HPV test, and the sample included those
who were reported both positive and negative at
the second test (see Figure 1). Approximately 40%
of women tested positive at follow-up (unpublished
data), although without typing data, it is impos-
sible to diﬀerentiate between new and persistent
infections. Within the positive group, women were
given a choice of management: immediate colpo-
scopy versus repeat HPV testing in a further 12
months. The study aimed to include women from
both management option groups.
Women were selected using purposive sampling
to ensure a heterogeneous sample in terms of age,
marital status and socio-economic background.
Although we ensured that women from both
management option groups were included, we
could not include equal numbers because very
few women opted for repeat HPV testing. The vast
majority of women opted for immediate colpo-
scopy, so we decided to concentrate on this group.
Procedure
Women were sent a letter informing them about
the study, and were given the opportunity to opt
out if they did not wish to participate. Those who
had not opted out were contacted by telephone and
invited to take part. In-depth, semi-structured
interviews were carried out in women’s homes (or
places of work if this was preferred) by the ﬁrst and
second authors or a trained freelance interviewer.
The interview was structured using a topic guide
covering general background, the two HPV tests,
emotional responses to the tests, diﬀerences be-
tween the impact of the two tests, disclosure of
results, decisions about follow-up and feelings
about future screening.
With the consent of participants, interviews were
recorded and transcribed verbatim. The transcripts
were analysed using Framework Analysis to
identify emerging themes and to organise the data
[14]. This is a matrix-based approach, with themes
making up the columns and cases making up the
rows of the matrix. The thematic framework is
developed through familiarisation with a sub-set of
transcripts. All data are summarised within the
framework and this organisation facilitates exam-
ination of both themes and cases, allowing
relationships between themes and explanations
for patterns within the data to be explored.
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Figure 1. Management of women within the ARTISTIC trial
and recruitment for interview
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Results
Sample
Demographic characteristics of the sample are
shown in Table 1.
The sample was well-distributed across the age
groups. Two-thirds were married or cohabiting. Of
the 21 women with persistent HPV, 17 opted for
immediate colposcopy rather than waiting for a
third HPV test 12 months later.
Emotional impact of being HPV positive over the
year between tests
The ﬁrst aim of the study was to examine the way
in which anxiety and concern about being HPV
positive played out over the course of the 12
months between the two tests. Three main patterns
of anxiety were described.
Initial anxiety that was then resolved
Feelings of shock, confusion and distress about
testing HPV positive were common. These feelings
frequently related to the sexually transmitted
nature of HPV and concerns were articulated
about where the virus had come from. Anxiety
about the health implications of HPV was also
expressed. Anxiety was often compounded by lack
of knowledge about HPV. These responses are
consistent with results from an earlier study [7,15].
Initial anxiety was often followed by seeking
further information about HPV from the internet,
the ARTISTIC trial helpline, or a GP. Once some
of the confusion had been resolved, women seemed
able to put the result to the back of their mind until
the next test. Particularly reassuring was the
knowledge that the virus could lie dormant for a
long time, so exposure was not necessarily recent
and its presence did not mean that a partner had
been unfaithful.
I mean if he’d had an aﬀair with somebody then I
would have been angry and upset. As it is . . . it’s
something that I think he’s had before our
relationship, I trust him a hundred per cent. (F5)
Women were also reassured by the fact that HPV
does not have symptoms, is highly prevalent and
can clear spontaneously without treatment.
The pattern of initial anxiety followed by
information seeking and reassurance is illustrated
by the following quotation from a woman who was
upset to be diagnosed with an STI, but whose
distress lessened after receiving reassurances from
the trial helpline.
I was quite annoyed, couldn’t really believe it that
it happened to me. And because it was sexually
transmitted, and because I haven’t had a lot of
partners. Yeah wasn’t very happy at all really. . . . I
phoned the [ARTISTIC Trial] helpline and they
reassured me, they really did reassure me so I felt
quite happy after talking with them. . . . I would say
it [the anxiety] lessened over the year because of the
chat I had with the helpline . . . I thought well if I
hadn’t taken part in that test I would never have
known I had it and I knew I was going to have
further tests. (F21)
On-going anxiety
This theme was characterised by the experience of
anxious thoughts about HPV on and oﬀ through-
out the year. The thoughts usually focused on
unanswered questions and confusion about certain
aspects of the virus. Women describing this
experience had usually not sought additional
information about HPV, or had not found
satisfactory answers to their questions, and so
seemed to dwell on the confusing and worrying
aspects of the virus, unable to resolve their
concerns. The need for a coherent model of the
infection was expressed, but it was often diﬃcult to
develop such a model from the information
available. For example, one woman had phoned
the ARTISTIC trial helpline, but still had ques-
tions about HPV which she reported thinking
about on a weekly basis.
Table 1. Demographic characteristics of the sample
HPV positive HPV negative
at follow-up at follow-up All
(n¼21) (n¼ 9) (n¼ 30)
Age
20s 7 1 8
30s 5 2 7
40s 6 3 9
50 and over 3 3 6
Relationship status
Single 4 0 4
In relationship 4 2 6
Married/cohabiting 12 7 19
Divorced 1 0 1
Education
Left school before
16/no qualifications
1 2 3
Left school at 16
(GCSEs, CSEs, O levels)
7 2 9
A levels 3 0 3
Further education
(diploma, BTech etc.)
5 2 7
Higher education
(degree)
4 3 7
Missing data 1 0 1
Choice of follow-up
Colposcopy 17 n/a 17
Repeat HPV test 4 n/a 4
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Like I say, the only thing that I do go back on is
like what is it? If I keep carrying on, how long will I
have it? What will they do for it? What will the long
term eﬀects be for me? They’re the questions that
go over a lot. The other things are just ﬂeeting
thoughts like now I sit and think about it. Could it
be that? Could it be this? . . . Every now and again
I’ll think about it for whatever the reason and
they’re my thoughts that I always have. (F9)
In addition to telephoning the trial helpline, this
woman had tried to obtain information from her
doctor but her concerns seem not to have been
taken seriously. She reported being told ‘It’s just a
study we’re doing. It’s nothing to worry about’.
The explanations she had received were not clear
enough for her to understand:
No one has actually, in my terms, made me
understand what it is. They kind of give me long
words and terms that go a bit over my head. (F9)
Another woman had a similar experience. She
worried about when she had caught HPV and from
whom, and was concerned about whether her long-
term partner might have been unfaithful. She was
also concerned about her risk of cancer. When she
attended for colposcopy, she tried to talk to a
doctor about it and reported:
She wasn’t prepared to discuss anything with me.
She just said go on the internet (F28)
This woman did not have access to the internet at
home, and also felt scared about what she might
ﬁnd out if she looked.
Women in this group tended to have few
educational qualiﬁcations and to be from lower
socio-economic backgrounds. This may have con-
tributed to their diﬃculty in accessing adequate
information about HPV, though this hypothesis
needs further empirical examination.
No anxiety
A third group of women were unconcerned about
their HPV positive result and claimed to have
forgotten about it completely between the two
tests. Even some of the women who had strongly
negative initial reactions then forgot about HPV
until they were recalled for the second test. This
response seemed to be associated with under-
standing that HPV could clear up on its own over
the year, that it was not serious or life-threatening,
and that their smear test result had been normal.
The asymptomatic nature of HPV was also cited as
a reason for being able to forget all about it.
Sometimes anxiety increased immediately prior to
the second test, as women wondered what the
result would be.
I think to be honest I probably forgot about it most
of the time until, I think, August when I realised I
had to go for another one [test]. Then I got a bit
anxious. How will it go? Will I still be positive?
(F10)
Impact of the second HPV result
The impact of a second HPV result was explored
and themes emerged relating to women’s emotional
and behavioural responses. Particular attention
was paid to the ways in which these diﬀered from
responses to the ﬁrst HPV result.
Emotional responses
Not surprisingly, emotional responses following
the second HPV test varied greatly by whether or
not that test was positive.
HPV positive at follow-up
Many women in the study described experiencing
similar feelings when they received their second
HPV positive result, as have been found in women
receiving a ﬁrst HPV positive result [7]. These
included fear and anxiety about cancer and
becoming ill, concerns about fertility, feelings of
being unclean because of the sexually transmitted
nature of HPV, concerns about transmission and
sexual relationships, a negative impact on feelings
about sex, and relationship issues including blam-
ing a partner for the infection.
There was some variation from the initial result
though, with concern often being greater after the
second test. This was partly related to having a
greater understanding of HPV the second time
around, and may also have been linked to the fact
that a colposcopy was oﬀered after the second test,
making it seem more serious.
The ﬁrst one you don’t know what it’s about
whereas with the second one it’s important to you.
When you ﬁnd out you’re positive again . . . you’re
like ahh! (F18)
There was a sense that something that ‘isn’t going
away’ must be more serious and more of a threat to
health than the ﬁrst result. After the second test,
fears about cancer and progression seemed to be
more of an issue than they had been initially.
I didn’t really know what HPV meant and then
when I worked it out and I thought God, what if I
can’t have children or something? Or I have got
cancer or something? (F13)
Hopes or expectations that the result would be
negative led to feelings of disappointment when the
virus had not been cleared. This was associated
with the belief that a strong immune system would
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ﬁght oﬀ the virus, and that this could be hampered
by stress or an unhealthy lifestyle. In some cases, a
second HPV positive result led to a sense of failure,
or of one’s body letting one down.
You know, when you’re thinking oh God my body
can’t ﬁght it oﬀ itself, my body can’t get rid of it
itself, it’s not good. (F18)
This negative impact was not universal though. In
some cases, the oﬀer of a colposcopy and
additional monitoring led to feelings of reassur-
ance. This was especially true if women knew that
cervical abnormalities could be treated easily if
they developed. Sometimes taking part in the trial
and receiving the oﬀer of regular testing and
colposcopy was seen as preferable to the standard
three year recall system, which was regarded by
many as too infrequent.
Another response was to regard the test as part
of research, and not something that was of
personal relevance. This enabled women to dis-
tance themselves from the result and avoid
experiencing any negative impact. This response
highlights the importance of the trial context in
shaping women’s experiences.
I just understood that it was one of these things
that women get and that’s what the whole research
was about}trying to ﬁnd out how and why, and
why some clear up and some don’t and all the rest
of it. That it was really just a piece of research
rather than anything that was threatening to me
personally. (F2)
HPV negative at follow-up
Testing negative was generally associated with
feeling ‘pleased’, ‘glad’ or relieved, as if a ‘big
weight [had been] lifted oﬀ your shoulders’. The
relief was connected with not needing further tests
or treatment and, for some, with a reduced risk of
cervical cancer.
[HPV] was something that was gone that was
possibly some kind of a risk, I don’t know. If it’s
something that it’s better not to have than to have,
then I’m glad I haven’t got it. (F6)
One woman was especially pleased about her
negative result as she interpreted it as meaning
that the HPV could not have come from her
current partner. She believed that if it had come
from him, he would have re-infected her during the
year, so her result would still have been positive.
There were some lingering concerns about future
fertility or about recurrence of the infection. There
was also uncertainty about whether a negative test
could be an indication that the virus was still lying
dormant and might reappear at a later date. This
was linked with a ‘herpes’ model of viral infections.
Among women who had expected still to be
positive, there was shock and surprise about the
negative result, but this was usually associated with
feelings of relief as well.
I just had a feeling it would still be there. I was
quite surprised when it said it was negative. I was
glad but . . . I was just surprised that it would have
just gone on its own. (F7)
The negative result was also welcomed as evidence
of the eﬀective functioning of the immune system.
I thought oh my body must be working then
because it’s fought it oﬀ now, it’s disappeared for
now. (F29)
Behavioural impact
In an earlier study, disclosure was found to be an
important coping response to testing HPV positive,
and was indicative of women’s emotional response
[7]. Most women in this study reported a consistent
pattern of disclosure across their two HPV results,
talking to the same people about their second as
their ﬁrst result. Some, though, did not talk to
anyone about their ﬁrst result, often because of the
perceived stigma associated with STIs, but were so
upset or worried about their second result that they
either felt the need to seek support and reassur-
ance, or were forced to explain to work colleagues
or their family what they were upset about. This
woman described telling her father about her
second positive result.
I think I wouldn’t have bothered [to tell my father]
if it wasn’t for the fact that I was so upset ‘cause I
didn’t bother the ﬁrst time round but second time
I was so upset and needed to get it oﬀ my chest
that I told him. It was quite diﬃcult! (F10)
In addition, some women chose to disclose follow-
ing a second positive result because they wanted
information or support about the colposcopy
procedure and possible treatment. This provides
further evidence that the emotional impact of the
second test was more negative and severe than the
ﬁrst result, and that some women were motivated
to overcome feelings of embarrassment about the
sexually transmitted nature of HPV in order to
gain information and support.
The relationship between anxiety and disclosure
was not straightforward. For some women, feeling
anxious led them to disclose their result and this
helped lessen their concerns when friends and
family were reassuring and supportive. For others,
disclosure was unhelpful because friends and
family had not heard of HPV and so were not
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able to provide the support that had been hoped
for. Because awareness of HPV is generally low,
some women chose not to talk about it, especially if
they lacked conﬁdence in their own ability to
explain it to someone else.
I haven’t really mentioned it at all I suppose ‘cause,
I don’t know, I’m hopeless at explaining things.
(F16)
Sometimes disclosure added to the burden of
anxiety because women then had to deal with the
concerns of others. One woman’s partner felt guilty
about having given her the virus, whereas she was
relatively unconcerned about it.
He [partner] just felt guilty. I think really what
scared him was the cancer thing with it. If he
thought that I had cervical cancer I don’t know
what he’d have done, I think he’d have just had a
nervous breakdown because he just would have felt
just so guilty about that. (F26)
Choice of follow-up among HPV positive women
The third aim of the study was to explore women’s
reasons for choosing each management option for
persistent HPV. As shown in Table 1, the majority
of women interviewed opted for colposcopy rather
than waiting another 12 months for a third HPV
test. Only four women in the sample decided to
wait, which reﬂected the pattern of choices in the
trial population as a whole (unpublished data).
Three women were unaware of having been oﬀered
a choice. Among those who had actively chosen a
particular management option, the reasons for the
choice were explored.
Reasons for choosing colposcopy
Anxiety was one reason for choosing to have a
colposcopy immediately. Some women were wor-
ried and upset by their second HPV positive result
and were not prepared to continue to worry for
another 12 months.
Well I thought maybe there was something a bit
wrong, I don’t know. To have two tests come back
that say positive I think then you start thinking well
what is it? What is wrong? I just would rather if
there was something wrong for it to be found
really. . . . I’d prefer to be looked at and examined
and be told everything’s ﬁne rather than for
another year to worry about yeah I’m positive
again, what does that mean to me? I’d rather be
checked really. (F9)
As the example illustrates, this was associated with
concerns about the meaning of a second positive
result, and fears about what might be wrong. Other
women exhibited less anxiety, but nevertheless
expressed a desire for immediate resolution and
reassurance, rather than a further period of
uncertainty. This was often associated with an
understanding that treatment might be oﬀered if
abnormalities were picked up during the colpo-
scopy.
‘Cause I’m the sort of person that I need to get
things sorted now. I’m a bit of a ﬁx-it person. . . . So
in that way I would have gone as far down the line
as I could have done before people said there’s
nothing more we can do. That was why I chose the
colposcopy. (F20)
There was widespread understanding that the
colposcopy was a more ‘thorough’ test, and many
women welcomed the opportunity to have further
investigation and reassurance, even if they were not
particularly concerned about anything being
wrong.
I think because that was the next piece in the
jigsaw. It was OK I’ve been here and it’s still
showing up as positive, a colposcopy now so we’ll
investigate it a bit further. Well go along and make
sure that there’s nothing there untoward. . . . I saw
it more as an investigation and quite probably
nothing would show up. (F19)
There was a sense among some women that waiting
12 months might allow something to develop which
could otherwise be dealt with now. This was
associated with the general belief that cancer is a
disease that can progress rapidly and therefore any
early detection or treatment must be important.
You nip things in the bud with cancer. The sooner
you get treatment the better it is. (F5)
Despite the general feeling that a colposcopy was
preferable to waiting for a year, concerns were
expressed about the procedure itself.
I was more worried about the procedure I think. At
that moment in time I was worried about the
procedure, I hadn’t thought past the result. I
thought more about how much it was going to
hurt and whether I’d have to take time oﬀ work all
that kind of stuﬀ. (F1)
Reasons for choosing a repeat HPV test
Of the four women opting for a repeat test, only
three were aware of having done so. The fourth
woman was, in fact, unaware of having tested
positive for HPV, and thought that annual screen-
ing for HPV was the standard trial protocol.
Among the other three women, two decided not
to go for the colposcopy because this was the
easiest option, and they were not concerned about
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their HPV results. Practical barriers to attending
for colposcopy outweighed any perceived beneﬁt
associated with attending.
If anyone gives me a choice of having treatment or
not if it’s not necessary, I mean if they said oh yes it
is necessary you have to go then I would go. But if
you’re giving me an easy way out then I’ll take the
easy way out. It’s the convenience I think. I wasn’t
quite sure how I would have it done, how I’d get
there. (F15)
When women were oﬀered a choice, some of those
who were not worried about their result interpreted
the colposcopy as not being essential and therefore
chose to avoid this additional procedure.
The third woman in this group displayed a more
avoidant response towards the colposcopy, and
described fear about what might be found. She
preferred to wait, and hoped that the problem
might go away.
I was quite tempted to go for the examination but
then I think fear and . . . I’m a bit scared about
what might be found and it got the better of me.
That sounds awful . . . but I think it’s a lot of case
of just ignore it, it might go away. (F23)
Discussion
Women in this study had received a positive HPV
result and then been re-tested a year later as part of
the ARTISTIC trial of HPV testing in cervical
cancer screening. The study found that although
many women reported distress, anxiety and confu-
sion following their ﬁrst HPV result, this usually
resolved and did not lead to on-going anxiety in the
period between the two tests. The negative emo-
tional impact of a second HPV positive result was
often reported to have been greater than the ﬁrst,
sometimes motivating women to overcome the
shame and embarrassment associated with having
an STI in order to mobilise social support though
disclosure of their result. This greater impact
encompassed both the issues relating to the
sexually transmitted nature of the virus and fears
about the health implications and cancer risk
associated with persistent infection. Women who
tested negative for HPV at follow-up reported
feeling happy and relieved.
In contrast to a recent study of patient choice in
the management of mild dyskaryosis [12], women
with persistent HPV in this qualitative study opted
overwhelmingly for an immediate colposcopy
rather than a third HPV test in a further 12
months. There is a variety of possible explanations
for this. As HPV is unfamiliar and poorly under-
stood, women are motivated to seek further testing
and, if necessary, treatment. This may have been
associated with a lack of understanding of the very
slow progression of HPV to CIN and cancer.
Secondly, the study took place in the context of a
clinical trial. This might mean that participants
diﬀered from the general screening population, and
were probably more in favour of testing in general.
This is reﬂected in some of the comments that
women made}they were generally inclined to take
up any test that was oﬀered and were keen to be
monitored more frequently than every three years.
The ﬁndings are consistent with US research which
shows enormous enthusiasm for frequent screening
despite the risk of false positives and unnecessary
investigation and treatment and perhaps represents
an assumption that any early detection must be a
good thing [16,17]. However, more research is
needed to see how pervasive the attitudes of the
women who opted for repeat testing are in the
wider UK population.
HPV testing identiﬁes individuals with an infec-
tion that puts them at risk of a more serious
condition, but no immediate intervention is re-
commended. This is in contrast to risk factors such
as high blood pressure or cholesterol which are
often treated in their own right, so when diagnosed,
people immediately receive medication or advice to
change their lifestyles. Receiving risk information
without being given any advice about reducing risk
might be expected to cause anxiety. However,
experimental studies have indicated that people
receiving positive (unfavourable) test results down-
play the threat compared with those receiving a
negative (favourable) result [18]. This denial eﬀect
seems to be strongest when, as in the case of HPV,
there is no recommended behaviour change to
reduce the threat [19]. This might explain why, in
most cases, the women in our study did not
experience ongoing anxiety after their HPV diag-
nosis. In the absence of any behavioural recom-
mendations, denial can be seen as an adaptive
response to a health threat. There is also evidence
from experimental studies that common conditions
are seen as less serious than rare ones [20], so the
provision of prevalence information about HPV
may have been important in reducing anxiety.
As medical technology advances, it is likely that
increasing numbers of people will have to deal with
risk information for which there are no behaviour-
al changes that reduce the threat of serious disease
(e.g. testing for prostate speciﬁc antigen). This
study suggests that such risk labelling is not
necessarily anxiety-inducing, and that ensuring
that prevalence information is widely disseminated
might be a means of reducing any possible negative
psychological consequences.
It is interesting that anxiety did not seem to have
a straightforward relationship with management
preference. Some women who were not anxious
about HPV still opted to have a colposcopy, and
one woman who was very anxious about it chose to
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wait, and hoped that the virus would go away on
its own. The need for a speedy resolution of the
problem seemed to be a strong motivating factor
for many women, but more research with larger
samples is needed to explore this. It is also possible
that if women had a better understanding of the
low disease risk associated with their HPV positive
status, they would be more willing to undergo
conservative management.
In line with other studies, information provision
emerged as an important means of reducing the
anxiety and confusion associated with testing
positive for HPV. Women who experienced on-
going anxiety between the two HPV tests were
frequently those who had unanswered questions
relating to the virus, and had not been able to
develop a coherent model of HPV. Providing
information addressing women’s concerns at the
time of the ﬁrst test might help to resolve confusion
more rapidly, but this hypothesis needs to be tested
empirically.
The ﬁndings of this study should be treated with
some caution as the HPV test results at baseline
coincided with a normal cytology result. If HPV
testing were the sole screening test then the
signiﬁcance of the test result could be greater. This
could have implications not only for the psycho-
logical impact of testing but also for adherence to
recommended follow-up. Women therefore need to
be fully informed and comfortable with HPV
testing. There needs to be consideration of the
emphasis on HPV as an infection and HPV as an
indicator of cancer risk.
Conclusions
The study indicates that most women do not
experience on-going anxiety between a ﬁrst HPV
positive result, and a second test a year later. This
suggests that annual recall could be an acceptable
form of management for women with normal
cytology but HPV positive results. However, the
more serious negative impact of a second HPV
positive test compared with the ﬁrst, and the
overwhelming desire among the women we selected
for interview for an immediate colposcopy, may
indicate that on-going monitoring using HPV
testing might be less acceptable to some women
than immediate referral for colposcopy if the
infection is persistent. This ﬁnding needs to be
tested among representative samples of women
undergoing HPV testing, but if found to be robust,
might have implications for the development of
screening policy for HPV testing.
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